Galaxy Medicare IPO will open on September 10, 2025, and close on September 12, 2025. It is a Book Built Issue, through which the company aims to raise about ₹22.31 crores, including a fresh issue of ₹17.86 crores and an offer for sale of up to 8,24,000 equity shares with a face value of ₹10 each.

The price band for the IPO is set at ₹51 to ₹54 per share. The allocation includes 50% for QIBs, 15% for HNIs, and 35% for retail investors. The shares are scheduled to list on the NSE on September 17, 2025, while the IPO allotment date is September 15, 2025.

Financially, the company posted a revenue of ₹36.94 crores in 2024, compared to ₹32.03 crores in 2023, and a profit of ₹3.71 crores in 2024, up from ₹1.57 crores in 2023. Based on these results, investors may consider subscribing to this IPO with a long-term perspective.

About Galaxy Medicare IPO

Galaxy Medicare, established in 1992, is a leading company engaged in the manufacturing, sale, and export of medical devices, POP bandages, and surgical dressings. With over 30 years of experience, the company holds 27 registered trademarks, including well-known brands such as POP BAND, POP CAST, G CAST, and CARETAPE.

By supplying its products to government health departments, major hospitals, and private organizations, Galaxy Medicare has built a strong and reliable presence in India. The company employs around 190 people and focuses on continuous improvement, product innovation, and cost efficiency to meet global standards.

Galaxy Medicare has a dedicated quality control unit that ensures products meet the required design, quality, and finish standards. All of its manufacturing units are well-equipped with modern tools, machinery, and technology, enabling the production of internationally accepted products.